Table 1.
Demographic, clinical, and laboratory characteristics in patients with diabetes on PD with glycemic indices (n = 1601) and those without glycemic indices (n = 1718).
| Variables | PD patients with HbA1c or GA measurement | PD patients without HbA1c or GA measurement | P value |
|---|---|---|---|
| n (male%) | 1601 (71.0) | 1718 (70.4) | 0.483 |
| Age, years | 63.9 ± 11.6 | 64.0 ± 12.1 | 0.635 |
| PD duration, m | 27 [13–50] | 25 [12–47] | 0.163 |
| Type 1 diabetes, % | 8.9 | 7.7 | 0.172 |
| CVD comorbidity, % | 24.7 | 29.6 | 0.098 |
| Smoking, % | 11.2 | 9.5 | 0.214 |
| Insulin, % | 35.4 | 32.4 | 0.196 |
| Oral antidiabetic agents, % | 42.2 | 38.6 | 0.146 |
| Diet therapy alone, % | 34.5 | 42.2 | 0.001 |
| Antihypertensive agents, % | 83.5 | 79.9 | 0.023 |
| HD combination, % | 20.0 | 17.0 | 0.022 |
| Anuric % | 18.8 | 17.9 | 0.646 |
| Total Kt/V | 1.8 ± 0.8 | 1.8 ± 0.8 | 0.914 |
| 2.5% glucose dialysate use, % | 41.6 | 37.0 | 0.043 |
| Icodextrin user, % | 47.2 | 42.6 | 0.052 |
| D/P Cr | 0.67 ± 0.13 | 0.66 ± 0.12 | 0.204 |
| APD user, % | 42.9 | 43.8 | 0.689 |
| Body mass index, kg/m2 | 24.5 ± 3.9 | 24.1 ± 3.8 | 0.049 |
| Hemoglobin, g/dL | 10.8 ± 1.3 | 10.7 ± 1.4 | 0.251 |
| Serum albumin, g/dL | 3.2 ± 0.5 | 3.2 ± 0.6 | 0.349 |
| Total cholesterol, mg/dL | 172 ± 40 | 176 ± 40 | 0.062 |
| HDL-cholesterol, mg/dL | 46 ± 16 | 46 ± 17 | 0.752 |
| C-reactive protein, mg/dL | 0.16 [0.08–0.46] | 0.20 [0.2–0.55} | 0.106 |
| Calcium, mg/dL | 8.6 ± 0.8 | 8.6 ± 0.8 | 0.997 |
| Phosphate, mg/dL | 5.2 ± 1.3 | 5.2 ± 1.4 | 0.962 |
| Intact-PTH, pg/mL | 152 [76–249] | 142 [80–247] | 0.367 |
APD, automated peritoneal dialysis; CVD, cardiovascular disease; GA, glycated albumin; HD, hemodialysis; HDL, high-density lipoprotein; PD, peritoneal dialysis; PTH, parathyroid hormone.